Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
BeOne Medicines
Janssen Research & Development, LLC
BeOne Medicines
National Cancer Institute (NCI)
Children's Cancer Group, China
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Novartis
BeOne Medicines
BeOne Medicines
PETHEMA Foundation
Merck Sharp & Dohme LLC
University of Ulm
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Eli Lilly and Company
The First Affiliated Hospital of Soochow University
Novartis
Hackensack Meridian Health
BeOne Medicines
AbbVie
AstraZeneca
Alliance for Clinical Trials in Oncology
Orca Biosystems, Inc.
BeOne Medicines
Amgen
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
Children's Oncology Group
Daiichi Sankyo
Children's Oncology Group
Gamida Cell ltd
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Dartmouth-Hitchcock Medical Center
AstraZeneca
Novartis
Dana-Farber Cancer Institute
Peking University People's Hospital
Acerta Pharma BV
Astellas Pharma Inc
Novartis
Galapagos NV
Syndax Pharmaceuticals